Immunomodulatory potential of cytokine-licensed human bone marrow-derived mesenchymal stromal cells correlates with potency marker expression profile
Stem Cells · 06.12.2024 · 42 (12) · 1040-1054
DOI: 10.1093/stmcls/sxae053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells, online erschienen am 29.08.2024. Verfasst von Jiemin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Institute, School of Medicine, University of Galway, Galway H91FD82, Ireland. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Cytokines. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science Foundation Ireland, Engineering and Physical Sciences Research Council, European Regional Development Fund.
Abstract (Originalsprache)
Cytokine(s) pre-activation/licensing is an effective way to enhance the immunomodulatory potency of mesenchymal stromal cells (MSCs). Currently, IFN-γ licensing received the most attention in comparison with other cytokines. After licensing human bone marrow-derived MSCs with pro-/anti-inflammatory cytokines IFN-γ, IL-1β, TNF-α, TGF-β1 alone or in combination, the in vitro immunomodulatory potency of these MSCs was studied by incubating with allogeneic T cells and macrophage-like THP-1 cells. In addition, immunomodulation-related molecules filtered by bioinformatics, complement 1 subcomponent (C1s), and interferon-induced GTP-binding protein Mx2 (MX2), were studied to verify whether to reflect the immunomodulatory potency. Herein, we reported that different cytokines cause different effects on the function of MSC. While TGF-β1 licensing enhances the capacity of MSCs to induce T cells with an immunosuppressive phenotype, IFN-γ-licensing strengthens the inhibitory effect of MSC on T cell proliferation. Both TGF-β1 and IFN-γ licensing can enhance the effect of MSC on reducing the expression of pro-inflammatory cytokines by M1 macrophage-like THP-1 cells. Interestingly, IFN-γ upregulates potential potency markers extracellular C1s and kynurenine (KYN) and intracellular MX2. These 3 molecules have the potential to reflect mesenchymal stromal cell immunomodulatory potency. In addition, we reported that there is a synergistic effect of TGF-β1 and IFN-γ in immunomodulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Regenerative Medicine Institute, School of Medicine, University of Galway, Galway H91FD82, Ireland.
- Changsha Centre for Disease Control and Prevention, Changsha, Hunan Province 410011, People's Republic of China.
- CURAM Centre for Research in Medical Devices, University of Galway, Galway H91FD82, Ireland.
- Discipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway H91TK33, Ireland.
ORCID-Profile: Thomas Ritter
Förderung
- Science Foundation Ireland
- Engineering and Physical Sciences Research Council
- European Regional Development Fund
Zitieren
APA
Wang, J., Zhou, Y., Donohoe, E., Canning, A., Moosavizadeh, S., Ryan, A. E., & Ritter, T. (2024). Immunomodulatory potential of cytokine-licensed human bone marrow-derived mesenchymal stromal cells correlates with potency marker expression profile. Stem Cells, 42(12), 1040-1054. https://doi.org/10.1093/stmcls/sxae053
Vancouver
Wang J, Zhou Y, Donohoe E, Canning A, Moosavizadeh S, Ryan AE, et al. Immunomodulatory potential of cytokine-licensed human bone marrow-derived mesenchymal stromal cells correlates with potency marker expression profile. Stem Cells. 2024;42(12):1040-1054. doi:10.1093/stmcls/sxae053
BibTeX
@article{Wang2024,
author = {Wang, Jiemin and Zhou, Yingying and Donohoe, Ellen and Canning, Aoife and Moosavizadeh, Seyedmohammad and Ryan, Aideen E and Ritter, Thomas},
title = {Immunomodulatory potential of cytokine-licensed human bone marrow-derived mesenchymal stromal cells correlates with potency marker expression profile},
journal = {Stem Cells},
year = {2024},
volume = {42},
number = {12},
pages = {1040--1054},
doi = {10.1093/stmcls/sxae053}
}
EUVIMED